Insulin Reduces Serum Glycosylphosphatidylinositol Phospholipase D Levels in Human Type I Diabetic Patients and Streptozotocin Diabetic Rats

Molecular Genetics and Metabolism - Tập 75 - Trang 154-161 - 2002
J.N. Schofield1, J.W. Stephens2, S.J. Hurel2, K.M. Bell3, J.B. deSouza1, T.W. Rademacher1
1Department of Immunology and Molecular Pathology, University College, London, United Kingdom
2Department of Diabetes and Endocrinology, Middlesex Hospital, London, United Kingdom
3Rodaris Pharmaceuticals, Oxford, United Kingdom

Tài liệu tham khảo

Villar, 1998, Phospholipase cleavage of glycosylphosphatidylinositol reconstituted in liposomal membranes, FEBS Lett, 432, 150, 10.1016/S0014-5793(98)00853-9 Villar, 1999, Towards the in vitro reconstitution of caveolae. Asymmetric incorporation of glycosylphosphatidylinositol (GPI) and gangliosides into liposomal membranes, FEBS Lett, 457, 71, 10.1016/S0014-5793(99)01010-8 Rademacher, 1994, Inositolphosphoglycan second messengers, Braz J Med Biol Res, 27, 327 Varela-Nieto, 1996, Cell signalling by inositol phosphoglycans from different species, Comp Biochem Physiol, 115B, 223, 10.1016/0305-0491(96)00087-9 Jones, 1997, Glycosyl-phosphatidylinositol-phospholipase D: A possible candidate for the generation of second messengers, Biochem Biophys Res Commun, 233, 432, 10.1006/bbrc.1997.6475 Low, 1988, Structural and functional roles of glycosyl-phosphatidylinositol in membranes, Science, 239, 268, 10.1126/science.3276003 Saltiel, 1990, Second messengers of insulin action, Diabetes Care, 13, 244, 10.2337/diacare.13.3.244 Jarett, 1982, Chemical mediator or mediators of insulin action: Response to insulin and mode of action, Fed Proc, 41, 2736 Shashkin, 1997, Insulin mediators in man: Effects of glucose ingestion and insulin resistance, Diabetologia, 40, 557, 10.1007/s001250050715 Kunjara, 2936, Inositol phosphoglycans in diabetes and obesity: Urinary levels of IPG A-type and IPG P-type, and relationship to pathophysiological changes, Molec Genet Metab, 68, 488, 10.1006/mgme.1999.2936 Lazar, 1994, Stimulation of glycogen synthesis by insulin in human erythroleukemia cells requires the synthesis of glycosylphosphatidylinositol, Proc Natl Acad Sci USA, 91, 9665, 10.1073/pnas.91.21.9665 Chan, 1998, Insulin-stimulated release of lipoprotein lipase by metabolism of its phosphatidylinositol anchor, Science, 241, 1670, 10.1126/science.2843987 Muller, 1993, The sulfonylurea drug, glimepiride, stimulates release of glycosylphosphatidylinositol-anchored plasma membrane proteins from 3T3 adipocytes, Biochem J, 289, 509, 10.1042/bj2890509 Muller, 1994, Stimulation of a glycosyl-phosphatidylinositol-specific phospholipase by insulin and the sulfonylurea, glimepiride, in rat adipocytes depends on increased glucose transport, J Cell Biol, 126, 1267, 10.1083/jcb.126.5.1267 Romero, 1998, Phosphatidylinositolglycan anchors of membrane proteins: Potential precursors of insulin mediators, Science, 240, 509, 10.1126/science.3282305 Lisanti, 1989, The distribution of glycosyl-phosphatidylinositol anchored proteins is differentially regulated by serum and insulin, Biochem Biophys Res Commun, 164, 824, 10.1016/0006-291X(89)91533-7 Ishihara, 1987, Involvement of phosphatidylinositol and insulin in the coordinate regulation of proteoheparan sulfate metabolism and hepatocyte growth, J Biol Chem, 262, 4708, 10.1016/S0021-9258(18)61253-0 Klip, 1988, Insulin-induced decrease in 5′-nucleotidase activity in skeletal muscle membranes, FEBS Lett, 238, 419, 10.1016/0014-5793(88)80524-6 Vila, 1990, Insulin activates glycerol-3-phosphate acyltransferase (de novo phosphatidic acid synthesis) through a phospholipid-derived mediator. Apparent involvement of Gi alpha and activation of a phospholipase C, Biochemistry, 29, 8735, 10.1021/bi00489a033 Metz, 1991, Production of glycosylphosphatidylinositol-specific phospholipase D by the islets of Langerhans, J Biol Chem, 266, 17733, 10.1016/S0021-9258(18)55185-1 Deeg, 1997, Regulation of glycosylphosphatidylinositol-specific phospholipase D secretion from βTC3 cells, Endocrinology, 138, 819, 10.1210/en.138.2.819 Xie, 1994, Expression and secretion of glycosylphosphatidylinositol-specific phospholipase D by myeloid cell lines, Biochem J, 297, 547, 10.1042/bj2970547 Schofield, 2000, Structure and expression of the human glycosylphosphatidylinositol phospholipase D1 (GPLD1) gene, Biochim Biophys Acta, 1494, 189, 10.1016/S0167-4781(00)00194-9 Allander, 1997, Hepatic nuclear factor 3 and high mobility group I/Y proteins bind the insulin response element of the insulin-like growth factor-binding protein-1 promoter, Endocrinology, 138, 4291, 10.1210/en.138.10.4291 Hari, 1997, Uptake and intracellular stability of glycosylphosphatidylinositol-specific phospholipase D in neuroblastoma cells, Biochim Biophys Acta, 1355, 293, 10.1016/S0167-4889(96)00143-7 Stadelmann, 1993, Distribution of glycosylphosphatidylinositol-specific phospholipase D mRNA in bovine tissue sections, Cell Tissue Res, 274, 547, 10.1007/BF00314552 Metz, 1992, Immunolocalization of a glycosylphosphatidylinositol-specific phospholipase D in mast cells found in normal tissue and neurofibromastosis lesions, Am J Pathol, 140, 1275 Shimomura, 2000, Decreased IRS-2 and increased SREBP-1c lead to mixed insulin resistance and sensitivity in livers of lipodystrophic and ob/ob mice, Mol Cell, 6, 77, 10.1016/S1097-2765(00)00009-5 Koopmans, 1997, Seven days of euglycaemic hyperinsulinemai induces insulin resistance for glucose metabolism but not hypertension, elevated catecholamine levels, or increased sodium retention in conscious normal rats, Diabetes, 46, 1572, 10.2337/diacare.46.10.1572